| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 56,152 | 24,643 | 16,890 | 33,483 | | Cost of Revenue | 17,670 | 10,075 | 8,424 | 13,767 | | | Gross Profit | 38,482 | 14,568 | 8,466 | 19,716 | | | Operating Expenses | | Research Development | 3,157 | 2,950 | 2,896 | 2,392 | | Selling General and Administrative | 10,725 | 9,083 | 8,855 | 7,457 | | Non Recurring |
-
| 1,085 | 953 |
-
| | Others | 345 | 347 | 348 | 1,068 | | | | Total Operating Expenses |
-
| 13,465 | 13,052 |
-
| | | | Operating Income or Loss | 24,255 | 1,103 | (4,586) | 8,799 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 48 | 93 | 153 | 355 | | Earnings Before Interest And Taxes | 24,303 | 1,196 | (4,433) | 9,154 | | Interest Expense | 148 | 153 | 158 | 161 | | Income Before Tax | 24,155 | 1,043 | (4,591) | 8,993 | | Income Tax Expense | 9,215 | 406 | (1,790) | 2,923 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,940 | 637 | (2,801) | 6,070 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,940 | 637 | (2,801) | 6,070 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,940 | $637 | ($2,801) | $6,070 |
|
0.02% Nasdaq 
0.33%
Income Statement
